Q12* (p.Gln12Ter) variant of PML (Protein PML)
Q12* (p.Gln12Ter) in PML (Protein PML) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes population frequency data and structural context.
Q12* (p.Gln12Ter) variant details
- p.Gln12Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.423
- CADD 33.00
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available
- Structural context available